Literature DB >> 2463822

Functional and topographical analyses of epitopes on bovine herpesvirus type 1 glycoprotein IV.

G Hughes1, L A Babiuk, S van Drunen Littel-van den Hurk.   

Abstract

Bovine herpesvirus type 1 (BHV-1) glycoprotein gIV was purified by affinity chromatography. Purified preparations showed two distinct components of 71 K and 140 K following electrophoresis in sodium dodecyl sulphate polyacrylamide gels. The polypeptides were separated, excised from the gel and used to immunize rabbits; the resulting antisera showed a high degree of cross reactivity indicating that these polypeptides represent monomeric and dimeric forms of the same glycoprotein. Purified gIV was also used to develop a gIV-specific panel of monoclonal antibodies. Neutralizing monoclonal antibodies directed against gIV were conjugated to horseradish peroxidase and subjected to competition binding assays by ELISA. Three distinct neutralizing antigenic domains on gIV were identified. Domain 1 comprised two overlapping epitopes, whereas domain 2 was represented by a single monoclonal antibody. The third antigenic domain was made up of a complex of four identical or overlapping epitopes designated 3a, b, c, and d. Evidence is presented suggesting that domain 1 of gIV may be involved in penetration of the virus into the cell.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2463822      PMCID: PMC7087229          DOI: 10.1007/bf01319808

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  18 in total

1.  Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus.

Authors:  G Campadelli-Fiume; M Arsenakis; F Farabegoli; B Roizman
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Synthesis and processing of bovine herpesvirus 1 glycoproteins.

Authors:  S van Drunen Littel-van den Hurk; L A Babiuk
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  Mechanisms of neutralization by monoclonal antibodies to different antigenic sites on the bovine herpesvirus type 1 glycoproteins.

Authors:  K Okazaki; E Honda; T Minetoma; T Kumagai
Journal:  Virology       Date:  1986-04-15       Impact factor: 3.616

4.  Antigenic structure of transmissible gastroenteritis virus. II. Domains in the peplomer glycoprotein.

Authors:  B Delmas; J Gelfi; H Laude
Journal:  J Gen Virol       Date:  1986-07       Impact factor: 3.891

5.  Neutralizing determinants defined by monoclonal antibodies on polypeptides specified by bovine herpesvirus 1.

Authors:  J K Collins; A C Butcher; C A Riegel; V McGrane; C D Blair; Y A Teramoto; S Winston
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

6.  Glycoprotein D protects mice against lethal challenge with herpes simplex virus types 1 and 2.

Authors:  D Long; T J Madara; M Ponce de Leon; G H Cohen; P C Montgomery; R J Eisenberg
Journal:  Infect Immun       Date:  1984-02       Impact factor: 3.441

7.  Hybrid plasmacytoma production: fusions with adult spleen cells, monoclonal spleen fragments, neonatal spleen cells and human spleen cells.

Authors:  R H Kennett; K A Denis; A S Tung; N R Klinman
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

8.  Vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D prevents latent herpes in mice.

Authors:  K J Cremer; M Mackett; C Wohlenberg; A L Notkins; B Moss
Journal:  Science       Date:  1985-05-10       Impact factor: 47.728

9.  Characterization of envelope proteins of infectious bovine rhinotracheitis virus (bovine herpesvirus 1) by biochemical and immunological methods.

Authors:  R L Marshall; L L Rodriguez; G J Letchworth
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

10.  Interactions of monoclonal antibodies and bovine herpesvirus type 1 (BHV-1) glycoproteins: characterization of their biochemical and immunological properties.

Authors:  S van Drunen Littel-van den Hurk; J V van den Hurk; J E Gilchrist; V Misra; L A Babiuk
Journal:  Virology       Date:  1984-06       Impact factor: 3.616

View more
  22 in total

1.  Comparison of intertypic antigenicity of Aino virus isolates by dot immunobinding assay using neutralizing monoclonal antibodies.

Authors:  K Yoshida; S Ohashi; T Kubo; T Tsuda
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

2.  Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

Authors:  P J Lewis; L A Babiuk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  Expression of glycoprotein gIII-human decay-accelerating factor chimera on the bovine herpesvirus 1 virion via a glycosyl phosphatidylinositol-based membrane anchor.

Authors:  X Liang; M Tang; T J Zamb; L A Babiuk; J Kowalski; M L Tykocinski
Journal:  J Virol       Date:  1993-08       Impact factor: 5.103

4.  Use of epitope mapping to identify a PCR template for protein amplification and detection by enzyme-linked immunosorbent assay of bovine herpesvirus type 1 glycoprotein D.

Authors:  Tomy Joseph; Japhet Lyaku; Robert A Fredrickson; Arnost Cepica; Frederick S B Kibenge
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

5.  Monoclonal antibodies that distinguish between encephalitogenic bovine herpesvirus type 1.3 and respiratory bovine herpesvirus type 1.1.

Authors:  C S Chung; L D Pearson; V K Ayers; J K Collins
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

6.  Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV.

Authors:  X P Liang; L A Babiuk; S van Drunen Littel-van den Hurk; D R Fitzpatrick; T J Zamb
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

7.  Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties.

Authors:  S van Drunen Littel-van den Hurk; M D Parker; D R Fitzpatrick; T J Zamb; J V van den Hurk; M Campos; R Harland; L A Babiuk
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

8.  Efficacy of an experimental BHV-1 subunit gIV vaccine in beef calves challenged with BHV-1 in aerosol.

Authors:  J Van Donkersgoed; D McCartney; S van Drunen Littel-van den Hurk
Journal:  Can J Vet Res       Date:  1996-01       Impact factor: 1.310

9.  Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154.

Authors:  Sharmila Manoj; Philip J Griebel; Lorne A Babiuk; Sylvia van Drunen Littel-van den Hurk
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

10.  Pseudorabies virus gIII and bovine herpesvirus 1 gIII share complementary functions.

Authors:  X P Liang; L A Babiuk; T J Zamb
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.